Dengue Testing Market size is expected to reach nearly US$ 915.99 Mn. by 2029 with the CAGR of 5.5% during the forecast period.Dengue Testing Market Overview:
Dengue fever is a mosquito-borne disease that affects people. ELISA or PCR-based blood tests are the most frequent methods for diagnosing the dengue virus. Rapid point-of-care assays, which have recently been developed, allow for early detection and notification of the disease.To know about the Research Methodology :- Request Free Sample Report
Dengue Testing Market Dynamics:
Rising cases of Dengue fever every year boosts the market growth. An increase in the prevalence of dengue fever and increased awareness initiatives to teach about the afflictions of dengue are driving the growth of the worldwide dengue virus diagnostic testing market. In recent years, the number of cases of dengue fever has risen dramatically. Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific are the major dengue-affected regions in the world. Around 500,000 of these cases progress to dengue haemorrhagic fever or severe dengue, a more severe form of the disease that causes up to 25,000 deaths worldwide each year. The demand for cost-efficient test kits with high specificity and sensitivity is driven by a lack of effective diagnostic tools and the high cost of existing test kits. As a result, firms in this market are currently concentrating on the development of cost-effective and reliable dengue diagnostic technologies. Climate change is projected to increase the prevalence of dengue fever, which will fuel the growth of the dengue testing market. Despite the high level of awareness of dengue prevention and treatment, there are a number of hurdles, including insufficient financing and resources, as well as a lack of a clear plan to address the growing difficulties associated with dengue epidemics in many parts of the world. Rapid urbanization, a lack of sanitation, increased international trade, and population movement stifles efforts to reduce pollution. The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Dengue Testing Market Segment Analysis:
Dengue Testing Market is segmented on the basis of Test Type and End-Users. Based on Test Type, the ELISA-based segment is expected to account for dominant market share during the forecast period. An enzyme-linked immunosorbent test (ELISA), which analyses anti-DENV IgM or IgG antibodies in patient serum, is the most extensively used approach for diagnosing dengue fever. Early detection and treatment of dengue fever help to lower morbidity and fatality rates associated with severe forms of the disease, as well as the danger of larger outbreaks. In 2022, the EIA/ELISA category dominated the immunoassay market, with a revenue share of 63.7%. Reduced test time, quantitative results, and the use of less antisera for analysis are some of the key advantages of this technology over Immunoelectrophoresis and immunodiffusion. Furthermore, due to new product introductions, technological developments, and accuracy, RT-PCR testing is expected to rise at a significant rate. For example, in April 2022, Beroni Group Limited and Columbia University inked an exclusive license agreement under which Columbia University granted Beroni and its affiliates worldwide distribution rights to the patented CII-ArboViroPlex rRT-PCR assay.Dengue Testing Market Regional Insights:
APAC is expected to account for significant market share during forecast period. Because there are millions of instances of dengue infection each year, Asia Pacific is determined to be leading in the worldwide dengue testing market. Since 2009, the number of dengue cases in India has increased gradually, and the total number of deaths in 2022 was the most in the prior decade. Dengue fever is most prevalent in Southeast Asia, and the disease is on the rise. As a result of the rising frequency of infectious diseases, especially dengue fever, in India, Pakistan, and Sri Lanka, the market for dengue testing in the Asia Pacific is rapidly growing. There were 3.1 million instances in the American region alone, with over 25,000 of them categorized as severe. Despite the frightening number of infections, dengue-related mortality was down from the previous year. The report also helps in understanding Global Dengue Testing Market dynamics, structure by analyzing the market segments and project the Global Dengue Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.Dengue Testing Market Scope: Inquire before buying
Global Dengue Testing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 629.68 Mn. Forecast Period 2023 to 2029 CAGR: 5.5% Market Size in 2029: US $ 915.99 Mn. Segments Covered: by Test Type ELISA-based Tests RT-PCR based Tests Dengue IgG/IgM Rapid Test Other Tests by End-Users Hospitals Diagnostic Centers Others Dengue Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Dengue Testing Market, Key Players are
1. Thermo Fisher Scientific Inc. 2. Roche Molecular Systems Inc. 3. Abbott Laboratories 4. Abnova Corporation 5.InBios International, Inc. 6.NovaTec Immundiagnostica GmbH 7. Euroimmun AG (Sub. PerkinElmer) 8. Quest Diagnostics 9. Certest Biotec S.L. 10. OriGene Technologies 11. Arkray Inc. 12. Ceres Nanosciences Inc. 13. Corgenix Medical Corp 14. FK-Biotecnologia SA 15. QuantuMDx Group Ltd. 16. Sansure Biotech Inc. 17. Quidel Corp Frequently Asked Questions: 1. Which region has the largest share in Global Dengue Testing Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Dengue Testing Market? Ans: The Global Dengue Testing Market is growing at a CAGR of 5.5% during forecasting period 2023-2029. 3. What is scope of the Global Dengue Testing market report? Ans: Global Dengue Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Dengue Testing market? Ans: The important key players in the Global Dengue Testing Market are – Thermo Fisher Scientific Inc., Roche Molecular Systems Inc., Abbott Laboratories, Abnova Corporation, InBios International, Inc., NovaTec Immundiagnostica GmbH, Euroimmun AG (Sub. PerkinElmer), Quest Diagnostics, Certest Biotec S.L., OriGene Technologies, Arkray Inc., Ceres Nanosciences Inc., Corgenix Medical Corp, FK-Biotecnologia SA, QuantuMDx Group Ltd., Sansure Biotech Inc., and Quidel Corp 5. What is the study period of this market? Ans: The Global Dengue Testing Market is studied from 2022 to 2029.
1. Dengue Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Dengue Testing Market: Dynamics 2.1. Dengue Testing Market Trends by Region 2.1.1. North America Dengue Testing Market Trends 2.1.2. Europe Dengue Testing Market Trends 2.1.3. Asia Pacific Dengue Testing Market Trends 2.1.4. Middle East and Africa Dengue Testing Market Trends 2.1.5. South America Dengue Testing Market Trends 2.2. Dengue Testing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Dengue Testing Market Drivers 2.2.1.2. North America Dengue Testing Market Restraints 2.2.1.3. North America Dengue Testing Market Opportunities 2.2.1.4. North America Dengue Testing Market Challenges 2.2.2. Europe 2.2.2.1. Europe Dengue Testing Market Drivers 2.2.2.2. Europe Dengue Testing Market Restraints 2.2.2.3. Europe Dengue Testing Market Opportunities 2.2.2.4. Europe Dengue Testing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Dengue Testing Market Drivers 2.2.3.2. Asia Pacific Dengue Testing Market Restraints 2.2.3.3. Asia Pacific Dengue Testing Market Opportunities 2.2.3.4. Asia Pacific Dengue Testing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Dengue Testing Market Drivers 2.2.4.2. Middle East and Africa Dengue Testing Market Restraints 2.2.4.3. Middle East and Africa Dengue Testing Market Opportunities 2.2.4.4. Middle East and Africa Dengue Testing Market Challenges 2.2.5. South America 2.2.5.1. South America Dengue Testing Market Drivers 2.2.5.2. South America Dengue Testing Market Restraints 2.2.5.3. South America Dengue Testing Market Opportunities 2.2.5.4. South America Dengue Testing Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Dengue Testing Industry 2.8. Analysis of Government Schemes and Initiatives For Dengue Testing Industry 2.9. Dengue Testing Market Trade Analysis 2.10. The Global Pandemic Impact on Dengue Testing Market 3. Dengue Testing Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 3.1.1. ELISA-based Tests 3.1.2. RT-PCR based Tests 3.1.3. Dengue IgG/IgM Rapid Test 3.1.4. Other Tests 3.2. Dengue Testing Market Size and Forecast, by End User (2022-2029) 3.2.1. Hospitals 3.2.2. Diagnostic Centers 3.2.3. Others 3.3. Dengue Testing Market Size and Forecast, by Region (2022-2029) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Dengue Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 4.1.1. ELISA-based Tests 4.1.2. RT-PCR based Tests 4.1.3. Dengue IgG/IgM Rapid Test 4.1.4. Other Tests 4.2. North America Dengue Testing Market Size and Forecast, by End User (2022-2029) 4.2.1. Hospitals 4.2.2. Diagnostic Centers 4.2.3. Others 4.3. North America Dengue Testing Market Size and Forecast, by Country (2022-2029) 4.3.1. United States 4.3.1.1. United States Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 4.3.1.1.1. ELISA-based Tests 4.3.1.1.2. RT-PCR based Tests 4.3.1.1.3. Dengue IgG/IgM Rapid Test 4.3.1.1.4. Other Tests 4.3.1.2. United States Dengue Testing Market Size and Forecast, by End User (2022-2029) 4.3.1.2.1. Hospitals 4.3.1.2.2. Diagnostic Centers 4.3.1.2.3. Others 4.3.2. Canada 4.3.2.1. Canada Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 4.3.2.1.1. ELISA-based Tests 4.3.2.1.2. RT-PCR based Tests 4.3.2.1.3. Dengue IgG/IgM Rapid Test 4.3.2.1.4. Other Tests 4.3.2.2. Canada Dengue Testing Market Size and Forecast, by End User (2022-2029) 4.3.2.2.1. Hospitals 4.3.2.2.2. Diagnostic Centers 4.3.2.2.3. Others 4.3.3. Mexico 4.3.3.1. Mexico Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 4.3.3.1.1. ELISA-based Tests 4.3.3.1.2. RT-PCR based Tests 4.3.3.1.3. Dengue IgG/IgM Rapid Test 4.3.3.1.4. Other Tests 4.3.3.2. Mexico Dengue Testing Market Size and Forecast, by End User (2022-2029) 4.3.3.2.1. Hospitals 4.3.3.2.2. Diagnostic Centers 4.3.3.2.3. Others 5. Europe Dengue Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.2. Europe Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3. Europe Dengue Testing Market Size and Forecast, by Country (2022-2029) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.1.2. United Kingdom Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.2. France 5.3.2.1. France Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.2.2. France Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.3. Germany 5.3.3.1. Germany Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.3.2. Germany Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.4. Italy 5.3.4.1. Italy Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.4.2. Italy Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.5. Spain 5.3.5.1. Spain Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.5.2. Spain Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.6. Sweden 5.3.6.1. Sweden Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.6.2. Sweden Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.7. Austria 5.3.7.1. Austria Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.7.2. Austria Dengue Testing Market Size and Forecast, by End User (2022-2029) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 5.3.8.2. Rest of Europe Dengue Testing Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific Dengue Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.2. Asia Pacific Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3. Asia Pacific Dengue Testing Market Size and Forecast, by Country (2022-2029) 6.3.1. China 6.3.1.1. China Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.1.2. China Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.2. S Korea 6.3.2.1. S Korea Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.2.2. S Korea Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.3. Japan 6.3.3.1. Japan Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.3.2. Japan Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.4. India 6.3.4.1. India Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.4.2. India Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.5. Australia 6.3.5.1. Australia Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.5.2. Australia Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.6. Indonesia 6.3.6.1. Indonesia Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.6.2. Indonesia Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.7. Malaysia 6.3.7.1. Malaysia Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.7.2. Malaysia Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.8. Vietnam 6.3.8.1. Vietnam Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.8.2. Vietnam Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.9. Taiwan 6.3.9.1. Taiwan Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.9.2. Taiwan Dengue Testing Market Size and Forecast, by End User (2022-2029) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 6.3.10.2. Rest of Asia Pacific Dengue Testing Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa Dengue Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 7.2. Middle East and Africa Dengue Testing Market Size and Forecast, by End User (2022-2029) 7.3. Middle East and Africa Dengue Testing Market Size and Forecast, by Country (2022-2029) 7.3.1. South Africa 7.3.1.1. South Africa Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 7.3.1.2. South Africa Dengue Testing Market Size and Forecast, by End User (2022-2029) 7.3.2. GCC 7.3.2.1. GCC Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 7.3.2.2. GCC Dengue Testing Market Size and Forecast, by End User (2022-2029) 7.3.3. Nigeria 7.3.3.1. Nigeria Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 7.3.3.2. Nigeria Dengue Testing Market Size and Forecast, by End User (2022-2029) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 7.3.4.2. Rest of ME&A Dengue Testing Market Size and Forecast, by End User (2022-2029) 8. South America Dengue Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 8.2. South America Dengue Testing Market Size and Forecast, by End User (2022-2029) 8.3. South America Dengue Testing Market Size and Forecast, by Country (2022-2029) 8.3.1. Brazil 8.3.1.1. Brazil Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 8.3.1.2. Brazil Dengue Testing Market Size and Forecast, by End User (2022-2029) 8.3.2. Argentina 8.3.2.1. Argentina Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 8.3.2.2. Argentina Dengue Testing Market Size and Forecast, by End User (2022-2029) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Dengue Testing Market Size and Forecast, by Test Type (2022-2029) 8.3.3.2. Rest Of South America Dengue Testing Market Size and Forecast, by End User (2022-2029) 9. Global Dengue Testing Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Dengue Testing Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Thermo Fisher Scientific Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Roche Molecular Systems Inc. 10.3. Abbott Laboratories 10.4. Abnova Corporation 10.5. InBios International, Inc. 10.6. NovaTec Immundiagnostica GmbH 10.7. Euroimmun AG (Sub. PerkinElmer) 10.8. Quest Diagnostics 10.9. Certest Biotec S.L. 10.10. OriGene Technologies 10.11. Arkray Inc. 10.12. Ceres Nanosciences Inc. 10.13. Corgenix Medical Corp 10.14. FK-Biotecnologia SA 10.15. QuantuMDx Group Ltd. 10.16. Sansure Biotech Inc. 10.17. Quidel Corp 11. Key Findings 12. Industry Recommendations 13. Dengue Testing Market: Research Methodology 14. Terms and Glossary